Hot Pursuit     18-Mar-24
Dr Lal PathLabs appoints Shanka Banerjee as CEO
Dr Lal PathLabs said that its board of directors has approved the re-designation of Shankha Banerjee by appointing him as chief executive officer (CEO) with effect from 21 May 2024.
Banerjee is an alumnus of Delhi College of Engineering and SP Jain Institute of Management & Research, Mumbai. He has also done ‘BP Sales and Marketing Leadership Development Course’ at Kellogs, USA.

He joined Dr Lal PathLabs in July, 2014 as chief operating officer-Region II. Thereafter, he got promoted as chief growth officer and then moved to chief operating officer. Presently, he is serving as chief executive officer-associates/group companies.

He worked for Castrol India & BP Lubricants for 14 years and went on to become global market space manager. Later he joined Pidilite Industries as president – sales & marketing, Middle East & Africa.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. The company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. As on 31 March 2023, the company has 277 clinical laboratories, 5,102 patient service centers (PSCs) and 10,938 pick-up points (PUPs).

The company reported a 53.98% surge in consolidated net profit of Rs 81.3 crore on 10.11% increase in revenue from operations to Rs 538.9 crore in Q3 FY24 over Q3 FY23.

The scrip declined 1.44% to end at Rs 2020.45 on Friday, 15 March 2024.

Previous News
  Dr Lal Pathlabs
 ( Results - Analysis 28-Jul-23   11:08 )
  Dr. Lal PathLabs to hold AGM
 ( Corporate News - 29-Jul-23   12:52 )
  Dr Lal Pathlabs fixes record date for final dividend
 ( Market Beat - Reports 17-May-22   18:37 )
  Dr Lal Pathlabs consolidated net profit declines 24.53% in the September 2022 quarter
 ( Results - Announcements 08-Nov-22   15:26 )
  Dr Lal Pathlabs
 ( Results - Analysis 17-May-22   18:38 )
  Dr. Lal PathLabs Q2 PAT slides 24% YoY to Rs 72 cr
 ( Hot Pursuit - 08-Nov-22   15:42 )
  Dr Lal Pathlabs consolidated net profit declines 56.02% in the June 2022 quarter
 ( Results - Announcements 29-Jul-22   13:45 )
  Dr. Lal PathLabs Q4 PAT tumble 27% YoY to Rs 61 cr
 ( Hot Pursuit - 17-May-22   16:56 )
  Dr Lal Pathlabs consolidated net profit declines 26.50% in the March 2022 quarter
 ( Results - Announcements 17-May-22   17:34 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 27-May-22   12:00 )
  Dr. Lal PathLabs AGM scheduled
 ( Corporate News - 22-May-21   11:12 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top